Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Synageva BioPharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SYNAGEVA BIOPHARMA CORP (GEVA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Mar 2015 Thomson Reuters Stock Report 11 $25.00

GEVA: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

27 Mar 2015 New Constructs, LLC 9 $25.00

Value Graph: SYNAGEVA BIOPHAR -- GEVA

27 Mar 2015 Ford Investor Services, Inc. 1 $12.00

ValuEngine Industry Report for Medical-biomed/genetics(GEVA)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

24 Mar 2015 ValuEngine, Inc. 10 $49.00

"The Economy Matters" Report for GEVA: the economy's impact on GEVA's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

23 Mar 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for GEVA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

23 Mar 2015 ValuEngine, Inc. 11 $25.00

TheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

22 Mar 2015 TheStreet.com Ratings 5 $10.00

TheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

15 Mar 2015 TheStreet.com Ratings 5 $10.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SYNAGEVA BIOPHARMA CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

13 Mar 2015 Jefferson Research 11 $20.00